Convening for the first time since Health Secretary Robert F. Kennedy Jr. reconstituted its roster and paused its operations, the panel holds significant authority over which preventive treatments insurers are required to cover. This week's gathering ends an extended hiatus to address several guidelines that have remained untouched for at least five years. The outcomes will directly influence nationwide access to routine clinical screenings. In addition to revising stalled guidance, the agenda includes a presentation on task force methods and an evidence review centered on healthy lifestyles to prevent cardiovascular disease in adults.
Key points
The influential panel establishes guidelines that determine which preventive care service…: The influential panel establishes guidelines that determine which preventive care services insurers must cover nationwide.
Several pending recommendations that were delayed following last year's meeting cancellat…: Several pending recommendations that were delayed following last year's meeting cancellations are finally awaiting finalization.
Members will also review cardiovascular disease prevention through healthy lifestyles alo…: Members will also review cardiovascular disease prevention through healthy lifestyles alongside discussions regarding task force methods.
Sources checked by our analysis pipeline: 1
WASHINGTON — A little-known but influential panel that recommends which preventive services must be covered by insurance will meet this week for the first time in more than a year, with a membership overhauled by health secretary Robert F. Kennedy Jr.
The U.S. Preventive Services Task Force will meet to review recommendations related to cervical cancer, perinatal depression and unhealthy alcohol use in teens and adults, all of which have not been updated in at least five years, and have been awaiting finalization since last year, when Kennedy canceled the group’s meetings.
The task force will also hear an “evidence presentation on healthy lifestyles to prevent cardiovascular disease in adults,” and hear presentations from subject matter experts on screening for chronic kidney disease, colorectal cancer and lung cancer, as well as a discussion on “task force methods,” according to a notice sent Wednesday by the Agency for Healthcare Research and Quality.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Multiple Palestinian pedestrians, including four women, were injured on Wednesday after a vehicle targeted them across several separate sites in Kafr Qassem. Several of the victims sustained moderate injuries that required immediate transport to a local hospital for medical treatment. The vehicular assault was partially captured on camera, providing visual documentation of the attacks.
Patients diagnosed with a rare neurological disorder now have their first-ever treatment option authorized for use in the United States. The regulatory clearance introduces a dedicated pharmaceutical therapy where no approved medical alternatives previously existed. This development marks an unprecedented therapeutic breakthrough for managing the condition.
The latest death highlights a widening public health emergency as the United States grapples with its most severe viral outbreak in more than three decades. Driven largely by vaccine hesitancy, sustained transmission recently forced international authorities to revoke the nation's long-standing elimination status. State and federal agencies are now deploying emergency resources to curb infections and rebuild population immunity.